Deutsche Bank analyst Chad Dillard says that while CB&I's Q2 results "disappointed significantly," he sees a "clear path" to the shares trading towards the $20 range again should management execute and avoid further cos overruns. Selling the Technology business for 120% of the company's market value, deleveraging and reducing costs by $100M annually would unlock value, Dillard tells investors in a research note titled "2Q Results, A Tough (and Large) Pill to Swallow." The analyst lowered his price target for CB&I shares to $21 from $25 and maintains a Buy rating on the name. The stock in premarket trading is down 22%, or $3.58, to $12.75.